Lytic bacteriophages in veterinary medicine: A therapeutic option against bacterial pathogens?

Archivos de Medicina Veterinaria

Volumn 46, Issue 2, 2014, Pages 167-179

  Borie, C ^a   Robeson, J ^b   Galarce, N ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE VALPARAÍSO   (Chile)

Author keywords

Bacterial food borne pathogens; Bacteriophages; Phage therapy

Indexed keywords

BACTERIA (MICROORGANISMS);

EID: 84907903712     PISSN: 0301732X     EISSN: 07176201     Source Type: Journal    
DOI: 10.4067/S0301-732X2014000200002     Document Type: Review

References (75)

1. Abedon S, C Thomas-Abedon. 2010. Phage Therapy Pharmacology. Curr Pharma Biotechnol 11, 28-47.
2. Atterbury RJ, MAP Van Bergen, F Ortiz, MA Lovell, JA Harris, A De Boer, JA Wagenaar, VM Allen, PA Barrow. 2007. Bacteriophage therapy to reduce Salmonella colonization of broiler chickens. Appl Environ Microbiol 73, 4543-4549.
3. Bach SJ, TA Mcallister, DM Veira, VPJ Gannon, RA Holley. 2003 Effect of bacteriophage DC22 on Escherichia coli O157:H7 in an artificial rumen system (Rusitec) and inoculated sheep. Anim Res 52, 89-101.
4. Barrow P, M Lovell, A Berchieri Jr. 1998. Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves. Clin Diagn Lab Inmunol 5, 294-298.
5. Bikard D, LA Marraffini. 2011. Innate and adaptive immunity in bacteria: mechanisms of programmed genetic variation to fight bacteriophages. Curr Opin Immunol 24, 15-20.
6. Boerlin P. 2010. Implications of antimicrobial agents as therapeutics and growth promoters in food animal production. In: Sabour P, Griffiths M (eds). Bacteriophages in the control of food- and waterborne pathogens. ASM Press. Washington, DC, USA, Pp 1-9.
7. Borie C, I Albala, P Sánchez, ML Sánchez, S Ramírez, C Navarro, MA Morales, J Retamales, J Robenson. 2008ª. Bacteriophage treatment reduces Salmonella colonization of infected chickens. Avian Dis 52, 64-67.
8. b. Prevención de la infección por Salmonella enterica subespecie enterica serotipo Enteritidis (Salmonella Enteritidis) en pollos mediante un bacteriófago. Arch Med Vet 40, 197-201.
9. Borie C, C Hauva, J Quiroga, V Bravo, P Retamal, J Retamales, J Robeson. 2011. Uso de bacteriófagos en gallinas de postura infectadas con Salmonella enterica serotipo Enteritidis: prevención de la colonización intestinal y reproductiva. Arch Med Vet 43, 85-89.
10. Borysowski J, B Weber-Da¸browska, AJ Górski. 2006. Current status and perspectives of phage therapy. Adv Clin Exp Med 15, 575-580.
11. Borysowski J, B Weber-Dabrowska. 2008. Bacteriophage endolysins as a novel class of antibacterial agents. J Exp Biol Med 231, 366-377.
12. Bren L. 2007. Bacteria-eating virus approved as food additive. FDA Consumer Magazine 41, 20-22.
13. Buckling A, M Brockhurst. 2012. Bacteria-virus coevolution. Adv Exp Med Biol 751, 347-370.
14. Callaway TR, TS Edrington, AD Brabban, RC Anderson, ML Rossman, MJ Engler, MA Carr, KJ Genovese, JE Keen, ML Looper, EM Kutter, DJ Nisbet. 2008. Bacteriophage isolated from feedlot cattle can reduce Escherichia coli O157:H7 populations in ruminant gastrointestinal tracts. Foodborne Pathog Dis 5, 183-191.
15. Capparelli R, N Nocerino, M Iannaccone, D Ercolini, M Parlato, M Chiara, D Iannelli. 2010. Bacteriophage therapy of Salmonella enterica: a fresh appraisal of bacteriophage therapy. J Infect Dis 201, 52-61.
16. Carlton RM. 1999. Phage therapy: past history and future prospects. Arch Immunol Ther Experiment 47, 267-274.
17. Carlton RM, WH Noordman, B Biswas, ED De Meester, MJ Loessner. 2005. Bacteriophage P100 for control of Listeria monocytogenes in foods: genome sequence, bioinformatic analyses, oral toxicity study, and application. Regul Toxicol Pharmacol 43, 301-312.
18. Carvalho CM, BW Gannon, DE Halfhide, SB Santos, CM Hayes, JM Roe, J Azeredo. 2010. The in vivo efficacy of two administration routes of a phage cocktail to reduce numbers of Campylobacter coli and Campylobacter jejuni in chickens. BMC microbiology 10, 232-243.
19. CDC, Centers for Disease Control and Prevention. 1998. Preventing emerging infectious diseases: a strategy for the 21st century overview of the updated CDC Plan.
20. Ceyssens PJ, R Lavigne. 2010. Introduction to bacteriophage biology and diversity. In: Sabour P, Griffiths M (eds). Bacteriophages in the control of food and waterborne pathogens. ASM Press. Washington, DC, USA, Pp 11-29.
21. Dabrowska K, K Switala-Jelen, A Opolski, B Weber-Dabrowska, A Gorski. 2005. Bacteriophage penetration in vertebrates. J Appl Microbiol 98, 7-13.
22. Filho R, J Higgins, S Higgins, G Gaona, A Wolfenden, G Tellez, G, B Hargis. 2007. Ability of bacteriophages isolated from different sources to reduce Salmonella enterica serovar Enteritidis in vitro and in vivo. Poultry Sci 86, 1904-1909.
23. Fiorentin L, ND Vieira, W Barioni. 2005. Oral treatment with bacteriophages reduces the concentration of Salmonella Enteritidis PT4 in caecal contents of broilers. Avian Pathol 34, 258-263.
24. Freitag T, RA Squires, J Schmid. 2008. Naturally occurring bacteriophages lyse a large proportion of canine and feline uropathogenic Escherichia coli isolates in vitro. Res Vet Sci 85, 1-7.
25. García P, B Martínez, JM Obeso, A Rodríguez. 2008. Bacteriophages and their application in food safety. Lett Appl Microbiol 47, 479-485.
26. Gill JJ, JC Pacan, ME Carson, KE Leslie, MW Griffiths, PM Sabour. 2006. Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattle. Antimicrob Agents Chemother 50, 2912-2918.
27. Gorski A, B Weber-Dabrowska. 2004. The potential role of endogenous bacteriophages in controlling invading pathogens. Cell Mol Life Sci 62, 511-519.
28. Hagens S, MJ Loessner. 2007. Application of bacteriophages for detection and control of foodborne pathogens. Appl Microbiol Biotechnol 76, 513-519.
29. Hawkins C, D Harper, D Burch, E Anggard, J Soothill. 2010. Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: A before/after clinical trial. Vet Microbiol 146, 309-313.
30. Higgins S, JP Higgins, I Bielke, B Hargis. 2007. Selection and application of bacteriophages for treating Salmonella Enteritidis infections in poultry. Int Jour Poultry Sci 6, 163-168.
31. Hudson JA, C Billington, G Carey-Smith, G Greening. 2005. Bacteriophages as biocontrol agents in food. J Food Prot 68, 426-437.
32. Huff WE, GR Huff, NC Rath, JM Balog, AM Donoghue. 2003. Bacteriophage treatment of a severe Escherichia coli respiratory infection in broiler chickens. Avian Dis 47, 1399-1405.
33. Joerger RD. 2003. Alternatives to antibiotics: bacteriocins, antimicrobial peptides and bacteriophages. Poultry Sci 82, 640-647.
34. Johnson RB, CL Gyles, WE Huff, S Ojha, GR Huff, NC Rath, AM Donoghue. 2008 Bacteriophages for prophylaxis and therapy in cattle, poultry and pigs. Anim Health Res Rev 9, 201-215.
35. Koo J, DL Marshall, A Depaola. 2001. Antacid increases survival of Vibrio vulnificus and Vibrio vulnificus phage in a gastrointestinal model antacid increases survival of Vibrio vulnificus and Vibrio vulnificus phage in a gastrointestinal model. Appl Environ Microbiol 67, 2895-2902.
36. Kutter E, A Sulakvelidze. 2005. Bacteriophages: biology and applications. CRC Press, Boca Raton, Fla, USA.
37. Labrie SJ, JE Samson, S Moineau. 2010. Bacteriophage resistance mechanisms. Nat Rev Microbiol 8, 317-327.
38. Lee N, DL Harris. 2001. Effect of bacteriophage treatment as a preharvest intervention strategy to reduce the rapid dissemination of Salmonella Typhimurium in pigs. Proc. AASV American Association of Swine Veterinarians, Perry, IA, USA, Pp 555-557.
39. Lee N, DL Harris. 2003. Compositions and methods for reducing the amount of Salmonella in livestock. US Patent 6, 656, 463, USA.
40. Letellier L, P Boulanger, L Planc¸on, P Jacquot, M Santamaria. 2004 Main features on tailed phage, host recognition and DNA uptake. Front in Biosc 9, 1228-1239.
41. Lim TH, MS Kim, DH Lee, HN Lee, JK Park, HN Youn, HJ Lee, SY Yang, YW Cho, JB Lee, SY Park, IS Choi, CS Song. 2012. Use of bacteriophages for biological control of Salmonella Enteritidis infection in chicken. Res Vet Sci 93, 1173-1178.
42. Loc-Carrillo C, ST Abedon. 2011. Pros and cons of phage therapy. Bacteriophage 1, 111-114.
43. Loc-Carrillo C, RJ Atterbury, A El-Shibiny, PL Connerton, E Dillon, A Scott, IF Connerton. 2005. Bacteriophage therapy to reduce Campylobacter jejuni colonization of broiler chickens. Appl Environ Microbiol 71, 6554-6563.
44. Lu TK, M Koeris. 2011. The next generation of bacteriophage therapy. Curr Opin Microbiol 14, 524-531.
45. Machado VS, MLS Bicalho, RV Pereira, LS Caixeta, JHJ Bittar, G Oikonomou, RO Gilbert, RC Bicalho. 2012. The effect of intrauterine administration of mannose or bacteriophage on uterine health and fertility of dairy cows with special focus on Escherichia coli and Arcanobacterium pyogenes. J Dairy Sci 95, 3100-3109.
46. Martínez-Borra J, S González, C López-Larrea. 2012. The origin of the bacterial immune response. Adv Exp Med Biol 738, 1-13.
47. Maura D, L Debarbieux. 2011. Bacteriophage as twenty-first century antibacterial tools for food and medicine. Appl Microbiol Biotechnol 90, 851-859.
48. Merril CR, B Biswas, R Carlton, NC Jensen, GJ Creed, S Zullo, S Adhya. 1996. Long-circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci USA 93, 3188-3192.
49. Monk AB, CD Rees, P Barrow, S Hagens, DR Harper. 2010. Bacteriophage applications: where are we now?. Letters Appl Microbiol 51, 363-369.
50. Nakai T. 2010. Application of bacteriophages for control of intectious diseases in aquaculture. In: Sabour PM, Griffiths MW (eds). Bacteriophage in the Control of Food- and Waterborne Pathogens. ASM Press, Washington DC, USA, Pp 257-272.
51. Nechaev S, K Severinov. 2008. The elusive object of desire-interactions of bacteriophages and their hosts. Curr Opin Microbiol 11, 186-193.
52. Newell DG, M Koopmans, L Verhoef, E Duizer, A Aidara-Kane, H Sprong, M Opsteegh, M Langelaar, J Threfall, F Scheutz, J Van Der Giessen, H Kruse. 2010. Food-borne diseases - The challenges of 20 years ago still persist while new ones continue to emerge. Int J Food Microbiol 139, 3-15.
53. Omnilytics Inc. 2007. Omnilytics announces USDA/FSIS allowance bacteriophage treatment E. coli O157:H7 on livestock. January 2. OmniLytics, Inc., Salt Lake City, UT, USA.
54. Payne RJ, VA Jansen. 2001. Understanding bacteriophage therapy as a density-dependent kinetic process. J Theor Biol 208, 37-48.
55. Pereira C, YJ Silva, AL Santos, A Cunka, NCM Gomes, A Almeida. 2011. Bacteriophages with potential for inactivation of fish pathogenic bacteria: survival, host specifity and effect on bacterial community structure. Mar Drugs 9, 2236-2255.
56. Raya RR, RA Oot, B Moore-Maley, S Wieland, TR Callaway, EM Kutter, AD Brabban. 2011. Naturally resident and exogenously applied T4-like and T5-like bacteriophages can reduce Escherichia coli O157:H7 levels in sheep guts. Bacteriophage 1, 15-24.
57. Rozema EA, TP Stephens, SJ Bach, EK Okine, RP Johnson, K Stanford, TA Mcallister. 2009 Oral and rectal administration of bacteriophages for control of Escherichia coli O157:H7 in feedlot cattle. J Food Protect 72, 241-250.
58. Santos TMA, EC Ledbetter, LS Caixeta, MLS Bicalho, RC Bicalho. 2011. Isolation and characterization of two bacteriophages with strong in vitro antimicrobial activity against Pseudomonas aeruginosa isolated from dogs with ocular infections. Am J Vet Res 72, 1079-1086.
59. Sashital DG, B Wiedenheft, JA Doudna. 2012. Mechanism of foreign DNA selection in a bacterial adaptive immune system. Mol Cell 46, 606-615.
60. Sheng H, HJ Knecht, IT Kudva, CJ Hovde. 2006. Application of bacteriophages to control Escherichia coli O157:H7 levels in ruminants. Appl Environ Microbiol 72, 5359-5366.
61. Sklar IB, RD Joerger. 2001. Attempts to utilize bacteriophage to combat Salmonella enterica serovar Enteritidis infection in chickens. J Food Saf 21, 15-30.
62. Skurnik M, E Strauch. 2006. Phage therapy: facts and fiction. J Med Microbiol 296, 5-14.
63. Slanetz L, E Jawetz. 1941. Isolation and characteristics of bacteriophages for Staphylococci of bovine mastitis. J Bacteriol 41, 447-455.
64. Smith HW, MB Huggins, KM Shaw. 1987. Factors influencing the survival and multiplication of bacteriophages in calves and in their environment. J Gen Microbiol 133, 1127-1135.
65. Stern A, R Sorek. 2011. The phage-host arms race: shaping the evolution of microbes. Bioessays 33, 43-51.
66. Sulakvelidze A, Z Alavidze, J Morris. 2001. Bacteriophage therapy. Antimicrob Agents Chemother 45, 649-659.
67. Sulakvelidze A, E Kutter. 2005. Bacteriophage therapy in humans. In: Kutter A, Sulakvelidze A (eds). Bacteriophages: Biology and Applications. CRC Press, Boca Raton, USA, Pp 381-436.
68. Sulakvelidze P, A Barrow. 2005. Phage therapy in animals and agribusiness. In: Kutter A, Sulakvelidze A (eds). Bacteriophages: Biology and Applications. CRC Press, Boca Raton, USA, Pp 335-380.
69. Summers WC. 2001. Bacteriophage therapy. Annu Rev Microbiol 55, 437-451.
70. Tanji Y, T Shimada, H Fukudomi, K Miyanaga, Y Nakai, H Unno. 2005. Therapeutic Use of Phage Cocktail for Controlling Escherichia coli O157:H7 in Gastrointestinal Tract of Mice. J Biosci Bioeng 100, 280-287.
71. Toro H, SB Price, AS Mckee, FJ Hoerr, J Krehling, M Perdue, L Bauermeister. 2005. Use of bacteriophages in combination with competitive exclusion to reduce Salmonella from infected chickens. Avian Dis 49, 118-124.
72. Wagenaar JA, MAP Van Bergen, MA Mueller, TM Wassenaar, RM Carlton. 2005. Phage therapy reduces Campylobacter jejuni colonization in broilers. Vet Microbiol 109, 275-283.
73. Wall SK, J Zhang, MH Rostagno, PD Ebner. 2010. Phage therapy to reduce preprocessing Salmonella infections in market-weight swine. Appl Environ Microb 76, 48-53.
74. WHO, World Health Organization. 2000. Overcoming antimicrobial resistance. World Health Organization (Report on Infectious Diseases), Geneva, Switzerland.
75. Xie H, X Zhuang, J Kong, G Ma, H Zhang. 2005. Bacteriophage Esc-A is an efficient therapy for Escherichia coli 3-1 caused diarrhea in chickens. J Gen Appl Micro 51, 159-163.